Kathrin LaFaver, MD Kathrin LaFaver, MD, a neurologist and lifestyle medicine specialist from Saratoga Springs, New York, interviewed Dean Ornish, MD, the founder and president of the nonprofit Preventive Medicine Research Institute in Sausalito, California, and a clinical professor of medicine at the University of California in San Francisco and San Diego, about his recent study …
When Christopher Rajkumar, MD, presented the positive results of ORBITA-2, the second placebo-controlled trial of percutaneous coronary intervention (PCI) in stable angina, you could almost feel the relief of cardiologists at the American Heart Association meeting. All is right again. Thank goodness. The first ORBITA trial stunned our community when it showed that PCI compared …
PHILADELPHIA — Percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD) reduces angina frequency, increases exercise capacity, and improves quality of life, results of a placebo-controlled, randomized trial show, confirming advantages that have never before been proven. “The effect of PCI was immediate, sustained over 12 weeks, and consistent across all endpoints,” …